Development of therapeutics for dementia targeting Abeta clearance
Project/Area Number |
20590697
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
General internal medicine (including Psychosomatic medicine)
|
Research Institution | Osaka University |
Principal Investigator |
SATO Naoyuki Osaka University, 大学院・医学系研究科, 寄付講座准教授 (70372612)
|
Project Period (FY) |
2008 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2009: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2008: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
Keywords | アルツハイマー病 / ベータ / アミロイド / ベータ・アミロイド / クリアランス / LRP-1 / 蛋白輸送 / 離散 |
Research Abstract |
We found that statin reduced Abeta level in mouse brain and identify its mechanism. Statin inhibited Abeta production and up-regulated Abeta clearance. Up-regulation of Abeta clearance seemed likely to be mediated by the increase of LRP-1 expression. Inhibition of protein isoprenylation is involved in both inhibition of Abeta production and up-regulation of Abeta clearance.
|
Report
(4 results)
Research Products
(78 results)
-
-
-
-
[Journal Article] Reduction of Brain β-amyloid (Aβ) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, thrpugh increase in degradation of amyloid precursor protein C-terminal fragnents (APP-CTFs) and Aβ clearance.2010
Author(s)
Shinohara M, Sato N, Kurinami H, Takeuchi D, Takeda S, Shimamura M, Yamashita T, Uchiyama Y, Rakugi H, Morishita R.
-
Journal Title
The Journal of Biological Chemistry 285
Pages: 22091-102
Related Report
Peer Reviewed
-
-
[Journal Article] Reduction of Brain β-amyloid (Aβ) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, thrpugh increase in degradation of amyloid precursor protein C-terminal fragnents (APP-CTFs) and Aβ clearance2010
Author(s)
Shinohara M, Sato N, Kurinami H, Takeuchi D, Takeda S, Shimamura M, Yamashita T, Uchiyama Y, Rakugi H, Morishita R.
-
Journal Title
The Journal of Biological Chemistry
Volume: 285
Pages: 22091-102
Related Report
Peer Reviewed
-
-
-
-
-
-
[Journal Article] Prevention of dementia by antihypertensive drugs : how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients and ACE-inhibitors.2009
Author(s)
Fournier A, Oprisiu-Fournier R, Serot JM, Godefroy O, Achard JM, Faure S, Mazouz H, Temmar M, Albu A, Bordet R, Hanon O, Gueyffier F, Wang J, Black S, Sato N.
-
Journal Title
Expert Rev Neurother 9(9)
Pages: 1413-31
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Possible mutual interaction between diabetes mellitus and Alzheimer's disease : Generation of novel transgenic mice models of Alzheimer's disease with diabetic conditions2009
Author(s)
Shuko Takeda, Naoyuki Sato, Kozue Uchio-Yamada, Kyoko Sawada, Takanori Kunieda, Daisuke Takeuchi, Hitomi Kurinami, Mitsuru Shinohara, Hiromi Rakugi, Ryuichi Morishita
Organizer
ICAD (International Conference on Alzheimer's Disease) 2009
Place of Presentation
Vienna, Austria
Year and Date
2009-07-15
Related Report
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-